Merck & Co Inc. (NYSE:MRK)
Wells Fargo Healthcare Conference
September 8, 2016 01:45 PM ET
Executives
Roger Dansey - SVP, Clinical Research of Oncology
Teri Loxam - VP, IR
Analysts
David Maris - Wells Fargo
David Maris
Good afternoon, everyone. I’m David Maris, Wells Fargo’s specialty pharmaceutical analyst and a large-cap pharmaceutical analyst too, although I haven’t launched on the large-cap pharmaceuticals yet. So, I don’t know if I can officially say that. But since we’re introducing a large-cap pharmaceutical company, I’ll take that title too.
